The impact of this inhibition on schizophrenia is comparable to the NMDA receptor antagonists and should depend upon the tissue specific expression of the receptor subunits, particularly pH-sensitive GluN2B subunit [82], in the neural network associated with schizophrenia. This evidence concerns the gene GRIN2B and schizophrenia.